Solutions Including Aggregation for DSCSA Timeline 2023
The United States enacted the Drug Quality and Security Act (DQSA) in November 2013 to combat drug counterfeiting. The first part of this act is a federal framework that addresses the quality of medicines, and the second part addresses the safety of the supply chain. In this article, we will explain how the second part of DQSA can be implemented in accordance with the requirements of the Drug Supply Chain Security Act (DSCSA) 2023. However, in order to better understand the DSCSA Timeline’s 2023 requirements, we first want to explain DSCSA’s milestones with a DSCSA timeline.
Timeline of DSCSA
2023 Requirements of DSCSA
The pharmaceutical industry of America completed the serialization of all pharma projects in 2017-2018. The next most aggressive challenge is to ensure that serialized drugs are traceable within the supply chain. Serialized drugs need to be aggregated to make sure that the drugs are traceable in the supply chain. In addition, pharmaceutical manufacturers are required to install a VRS (Verification Router Services) system.
Aggregation for full compliance with DSCSA Timeline
Pharmaceuticals on the US market and transport units that integrate these drugs (container case, bundle, pallet) have been serialized. But the DSCSA Timeline wants hierarchical aggregation of transport units. What does this mean?
In short, aggregation in the pharmaceutical industry is defined as the virtual connection of serialized transport units and serialized drugs within them. The most common method for this virtual connection is to create hierarchical data with a parent-child relationship. When this data is associated with the serialized transport unit, the aggregation is complete.
You can find our detailed article about this topic here.
Verification Router Services Installation
Each drugmaker is required to install a VRS system following the standard published by GS1. Thanks to this system, distributors, pharmacies, and end-users will be able to question whether the drug is counterfeit. The FDA and the pharmaceutical industry, which are currently conducting pilot studies, are expected to announce the results of pilot studies for VRS shortly.
VISIOTT, which has been producing machine solutions for serialization and aggregation of drugs for 15 years, helps keep your drugs traceable with Level 3 and Level 4 software solutions that follow DSCSA timeline requirements. By filling out the contact form, you can contact our local sales team and ask our experts all questions you are interested in.
Bottle Serialization and Aggregation in accordance with DSCSA Timeline
Serialization in bottles used in the American pharmaceutical industry is carried out on the label on the bottle. Thermal printers integrated into labeling machines are the most commonly used method to meet this requirement. Applying a helper code to bottles to meet the aggregation requirement and matching this helper code and the code on the bottle is a common method. The most common method for matching the helper code with the code on the body is 360-degree reading. After matching, the aggregation process can be easily completed by reading the helper codes on the bottom or cap of the bottles collectively.
For VISIOTT’s bottle serialization and aggregation line offering in accordance with DSCSA timeline requirements, please see the specifications of the stations below.
BLS-100
Bottle Labeling Station
Bottles are irreplaceable packaging materials that many manufacturers use to present their products to the end-user. It has many forms made of glass, plastic, and …
View ProductBPAS-100
360° Bottle Serialization Station
In operations where bottles are used as primary packaging, preliminary preparation of the serialization and aggregation operation can be done with VISIOTT 360° Bottle Serialization …
View ProductABAS-100
Automatic Bundle Aggregation Station
VISIOTT Automatic Bundle Aggregation Station, which has been designed in accordance with GMP guidelines, is an automatic solution for bundle aggregation operations. …
View ProductCarton Serialization and Aggregation in accordance with DSCSA Timeline
Cartons are easier to serialize than bottles. Because printing is done on a flat floor, and there is no need for a helper code for aggregation. Codes can be read collectively with a high-resolution camera.
There are also many technological alternatives to printing 2D code on cartons. Thermal Inkjet and Laser are the most commonly used technologies. Especially with advanced thermal inkjet technology, almost any surface can be printed with water and solvent-based inks. Thanks to our high-speed camera technology, you can perform 2D code control at 600 box minutes.
ISS-100
Carton Serialization Station
VISIOTT Carton Serialization Station serializes every single pharma carton with thermal inkjet technology. The serialization process takes place in accordance with different global traceability …
View ProductISSTE-200
Carton Serialization with Tamper Evident Labeling
One of the ways to ensure product safety is to apply a tamper-evident label to the packaging. VISIOTT ISSTE-200 Carton Serialization…
View ProductFCSS-100
Flat Carton Serialization Station
Many companies that use cartons in their packaging prefer to serialize unfolded flat cartons in their serialization operations to comply with product traceability regulations. The …
View ProductMAS-100
Manual Aggregation Station
VISIOTT Manual Aggregation Station is able to read multiple 1D/2D codes of the serialized products in a big surface by a special vision system. The …
View ProductSMAS-100
Semi-Automatic Aggregation Station
Companies that want the advantage of speed in production to be at the maximum level combine aggregation and packaging processes in order not to compromise …
View ProductABAS-100
Automatic Bundle Aggregation Station
VISIOTT Automatic Bundle Aggregation Station, which has been designed in accordance with GMP guidelines, is an automatic solution for bundle aggregation operations. …
View ProductFor VISIOTT TPS’s carton serialization and aggregation line offering in accordance with DSCSA requirements, please see the specifications of the stations below. You can contact our sales team for more detailed information.
Author: Emre ÖZDEN